Single domain antibodies: comparison of camel VH and camelised human VH domains
The antigen binding sites of conventional antibodies are formed primarily by the hypervariable loops from both the heavy and the light chain variable domains. Functional antigen binding sites can however also be formed by heavy chain variable domains (VH) alone. In vivo, such binding sites have evol...
Gespeichert in:
Veröffentlicht in: | Journal of immunological methods 1999-12, Vol.231 (1), p.25-38 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 38 |
---|---|
container_issue | 1 |
container_start_page | 25 |
container_title | Journal of immunological methods |
container_volume | 231 |
creator | Riechmann, Lutz Muyldermans, Serge |
description | The antigen binding sites of conventional antibodies are formed primarily by the hypervariable loops from both the heavy and the light chain variable domains. Functional antigen binding sites can however also be formed by heavy chain variable domains (VH) alone. In vivo, such binding sites have evolved in camels and camelids as part of antibodies, which consist only of two heavy chains and lack light chains. Analysis of the differences in amino acid sequence between the VHs of these camel heavy chain-only antibodies and VH domains from conventional human antibodies helped to design an altered human VH domain. This camelised VH proved, like the camel VH, to be a small, robust and efficient recognition unit formed by a single immunoglobulin (Ig) domain. Biochemical, structural and antigen binding characterisation properties of both camel VH domains and camelised human VH domains suggest that these can compete successfully with single chain variable domain (Fv) fragments from conventional antibodies in many applications. Of special importance in this respect is the use of such VH domains as enzyme inhibitors, for which they seem to be better suited than Fv fragments. This function appears to be closely related to their often very long third hypervariable loop, which is central for antigen recognition in their binding sites. |
doi_str_mv | 10.1016/S0022-1759(99)00138-6 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69415712</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022175999001386</els_id><sourcerecordid>69415712</sourcerecordid><originalsourceid>FETCH-LOGICAL-c458t-34b06c9ae9b0c84d1ff788aff3b570c53beb0bc69a9dfe5beabef7343c1b8ea53</originalsourceid><addsrcrecordid>eNqFkF1LwzAUhoMobk5_gtIr0Ytq0jRt443I8AsGu5h6G_JxopG2mUkn-O_t1iHe7erlHJ5zXngQOiX4imBSXC8wzrKUlIxfcH6JMaFVWuyhManKLC05Zvto_IeM0FGMn7incIEP0aiPvOIZG6P5wrXvNSTGN9K1iWw7p7xxEG8S7ZulDC76NvE20bKBOnl76hEzDC6CST5WjWzX6-FBPEYHVtYRTrY5Qa8P9y_Tp3Q2f3ye3s1SnbOqS2mucKG5BK6wrnJDrC2rSlpLFSuxZlSBwkoXXHJjgSmQCmxJc6qJqkAyOkHnw99l8F8riJ1oXNRQ17IFv4qi4DlhJcl2gqTMc0Yx7UE2gDr4GANYsQyukeFHECzWysVGuVj7FJyLjXJR9Hdn24KVasD8uxoc98DtAEDv49tBEFE7aDUYF0B3wni3o-IXPNuRLQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17445303</pqid></control><display><type>article</type><title>Single domain antibodies: comparison of camel VH and camelised human VH domains</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Riechmann, Lutz ; Muyldermans, Serge</creator><creatorcontrib>Riechmann, Lutz ; Muyldermans, Serge</creatorcontrib><description>The antigen binding sites of conventional antibodies are formed primarily by the hypervariable loops from both the heavy and the light chain variable domains. Functional antigen binding sites can however also be formed by heavy chain variable domains (VH) alone. In vivo, such binding sites have evolved in camels and camelids as part of antibodies, which consist only of two heavy chains and lack light chains. Analysis of the differences in amino acid sequence between the VHs of these camel heavy chain-only antibodies and VH domains from conventional human antibodies helped to design an altered human VH domain. This camelised VH proved, like the camel VH, to be a small, robust and efficient recognition unit formed by a single immunoglobulin (Ig) domain. Biochemical, structural and antigen binding characterisation properties of both camel VH domains and camelised human VH domains suggest that these can compete successfully with single chain variable domain (Fv) fragments from conventional antibodies in many applications. Of special importance in this respect is the use of such VH domains as enzyme inhibitors, for which they seem to be better suited than Fv fragments. This function appears to be closely related to their often very long third hypervariable loop, which is central for antigen recognition in their binding sites.</description><identifier>ISSN: 0022-1759</identifier><identifier>EISSN: 1872-7905</identifier><identifier>DOI: 10.1016/S0022-1759(99)00138-6</identifier><identifier>PMID: 10648925</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Amino Acid Sequence ; Animals ; Antibody engineering ; Camel ; Camelus ; Heavy chain ; Humans ; Immunoglobulin ; Immunoglobulin Heavy Chains - biosynthesis ; Immunoglobulin Heavy Chains - chemistry ; Immunoglobulin Heavy Chains - genetics ; Immunoglobulin Heavy Chains - immunology ; Immunoglobulin Variable Region - biosynthesis ; Immunoglobulin Variable Region - chemistry ; Immunoglobulin Variable Region - genetics ; Immunoglobulin Variable Region - immunology ; Molecular Sequence Data ; Recombinant Proteins - biosynthesis ; Recombinant Proteins - chemistry ; Recombinant Proteins - genetics ; Recombinant Proteins - immunology ; Single domain</subject><ispartof>Journal of immunological methods, 1999-12, Vol.231 (1), p.25-38</ispartof><rights>1999 Elsevier Science B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c458t-34b06c9ae9b0c84d1ff788aff3b570c53beb0bc69a9dfe5beabef7343c1b8ea53</citedby><cites>FETCH-LOGICAL-c458t-34b06c9ae9b0c84d1ff788aff3b570c53beb0bc69a9dfe5beabef7343c1b8ea53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0022-1759(99)00138-6$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10648925$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Riechmann, Lutz</creatorcontrib><creatorcontrib>Muyldermans, Serge</creatorcontrib><title>Single domain antibodies: comparison of camel VH and camelised human VH domains</title><title>Journal of immunological methods</title><addtitle>J Immunol Methods</addtitle><description>The antigen binding sites of conventional antibodies are formed primarily by the hypervariable loops from both the heavy and the light chain variable domains. Functional antigen binding sites can however also be formed by heavy chain variable domains (VH) alone. In vivo, such binding sites have evolved in camels and camelids as part of antibodies, which consist only of two heavy chains and lack light chains. Analysis of the differences in amino acid sequence between the VHs of these camel heavy chain-only antibodies and VH domains from conventional human antibodies helped to design an altered human VH domain. This camelised VH proved, like the camel VH, to be a small, robust and efficient recognition unit formed by a single immunoglobulin (Ig) domain. Biochemical, structural and antigen binding characterisation properties of both camel VH domains and camelised human VH domains suggest that these can compete successfully with single chain variable domain (Fv) fragments from conventional antibodies in many applications. Of special importance in this respect is the use of such VH domains as enzyme inhibitors, for which they seem to be better suited than Fv fragments. This function appears to be closely related to their often very long third hypervariable loop, which is central for antigen recognition in their binding sites.</description><subject>Amino Acid Sequence</subject><subject>Animals</subject><subject>Antibody engineering</subject><subject>Camel</subject><subject>Camelus</subject><subject>Heavy chain</subject><subject>Humans</subject><subject>Immunoglobulin</subject><subject>Immunoglobulin Heavy Chains - biosynthesis</subject><subject>Immunoglobulin Heavy Chains - chemistry</subject><subject>Immunoglobulin Heavy Chains - genetics</subject><subject>Immunoglobulin Heavy Chains - immunology</subject><subject>Immunoglobulin Variable Region - biosynthesis</subject><subject>Immunoglobulin Variable Region - chemistry</subject><subject>Immunoglobulin Variable Region - genetics</subject><subject>Immunoglobulin Variable Region - immunology</subject><subject>Molecular Sequence Data</subject><subject>Recombinant Proteins - biosynthesis</subject><subject>Recombinant Proteins - chemistry</subject><subject>Recombinant Proteins - genetics</subject><subject>Recombinant Proteins - immunology</subject><subject>Single domain</subject><issn>0022-1759</issn><issn>1872-7905</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkF1LwzAUhoMobk5_gtIr0Ytq0jRt443I8AsGu5h6G_JxopG2mUkn-O_t1iHe7erlHJ5zXngQOiX4imBSXC8wzrKUlIxfcH6JMaFVWuyhManKLC05Zvto_IeM0FGMn7incIEP0aiPvOIZG6P5wrXvNSTGN9K1iWw7p7xxEG8S7ZulDC76NvE20bKBOnl76hEzDC6CST5WjWzX6-FBPEYHVtYRTrY5Qa8P9y_Tp3Q2f3ye3s1SnbOqS2mucKG5BK6wrnJDrC2rSlpLFSuxZlSBwkoXXHJjgSmQCmxJc6qJqkAyOkHnw99l8F8riJ1oXNRQ17IFv4qi4DlhJcl2gqTMc0Yx7UE2gDr4GANYsQyukeFHECzWysVGuVj7FJyLjXJR9Hdn24KVasD8uxoc98DtAEDv49tBEFE7aDUYF0B3wni3o-IXPNuRLQ</recordid><startdate>19991210</startdate><enddate>19991210</enddate><creator>Riechmann, Lutz</creator><creator>Muyldermans, Serge</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7T5</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19991210</creationdate><title>Single domain antibodies: comparison of camel VH and camelised human VH domains</title><author>Riechmann, Lutz ; Muyldermans, Serge</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c458t-34b06c9ae9b0c84d1ff788aff3b570c53beb0bc69a9dfe5beabef7343c1b8ea53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Amino Acid Sequence</topic><topic>Animals</topic><topic>Antibody engineering</topic><topic>Camel</topic><topic>Camelus</topic><topic>Heavy chain</topic><topic>Humans</topic><topic>Immunoglobulin</topic><topic>Immunoglobulin Heavy Chains - biosynthesis</topic><topic>Immunoglobulin Heavy Chains - chemistry</topic><topic>Immunoglobulin Heavy Chains - genetics</topic><topic>Immunoglobulin Heavy Chains - immunology</topic><topic>Immunoglobulin Variable Region - biosynthesis</topic><topic>Immunoglobulin Variable Region - chemistry</topic><topic>Immunoglobulin Variable Region - genetics</topic><topic>Immunoglobulin Variable Region - immunology</topic><topic>Molecular Sequence Data</topic><topic>Recombinant Proteins - biosynthesis</topic><topic>Recombinant Proteins - chemistry</topic><topic>Recombinant Proteins - genetics</topic><topic>Recombinant Proteins - immunology</topic><topic>Single domain</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Riechmann, Lutz</creatorcontrib><creatorcontrib>Muyldermans, Serge</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of immunological methods</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Riechmann, Lutz</au><au>Muyldermans, Serge</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Single domain antibodies: comparison of camel VH and camelised human VH domains</atitle><jtitle>Journal of immunological methods</jtitle><addtitle>J Immunol Methods</addtitle><date>1999-12-10</date><risdate>1999</risdate><volume>231</volume><issue>1</issue><spage>25</spage><epage>38</epage><pages>25-38</pages><issn>0022-1759</issn><eissn>1872-7905</eissn><abstract>The antigen binding sites of conventional antibodies are formed primarily by the hypervariable loops from both the heavy and the light chain variable domains. Functional antigen binding sites can however also be formed by heavy chain variable domains (VH) alone. In vivo, such binding sites have evolved in camels and camelids as part of antibodies, which consist only of two heavy chains and lack light chains. Analysis of the differences in amino acid sequence between the VHs of these camel heavy chain-only antibodies and VH domains from conventional human antibodies helped to design an altered human VH domain. This camelised VH proved, like the camel VH, to be a small, robust and efficient recognition unit formed by a single immunoglobulin (Ig) domain. Biochemical, structural and antigen binding characterisation properties of both camel VH domains and camelised human VH domains suggest that these can compete successfully with single chain variable domain (Fv) fragments from conventional antibodies in many applications. Of special importance in this respect is the use of such VH domains as enzyme inhibitors, for which they seem to be better suited than Fv fragments. This function appears to be closely related to their often very long third hypervariable loop, which is central for antigen recognition in their binding sites.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>10648925</pmid><doi>10.1016/S0022-1759(99)00138-6</doi><tpages>14</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-1759 |
ispartof | Journal of immunological methods, 1999-12, Vol.231 (1), p.25-38 |
issn | 0022-1759 1872-7905 |
language | eng |
recordid | cdi_proquest_miscellaneous_69415712 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Amino Acid Sequence Animals Antibody engineering Camel Camelus Heavy chain Humans Immunoglobulin Immunoglobulin Heavy Chains - biosynthesis Immunoglobulin Heavy Chains - chemistry Immunoglobulin Heavy Chains - genetics Immunoglobulin Heavy Chains - immunology Immunoglobulin Variable Region - biosynthesis Immunoglobulin Variable Region - chemistry Immunoglobulin Variable Region - genetics Immunoglobulin Variable Region - immunology Molecular Sequence Data Recombinant Proteins - biosynthesis Recombinant Proteins - chemistry Recombinant Proteins - genetics Recombinant Proteins - immunology Single domain |
title | Single domain antibodies: comparison of camel VH and camelised human VH domains |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T03%3A26%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Single%20domain%20antibodies:%20comparison%20of%20camel%20VH%20and%20camelised%20human%20VH%20domains&rft.jtitle=Journal%20of%20immunological%20methods&rft.au=Riechmann,%20Lutz&rft.date=1999-12-10&rft.volume=231&rft.issue=1&rft.spage=25&rft.epage=38&rft.pages=25-38&rft.issn=0022-1759&rft.eissn=1872-7905&rft_id=info:doi/10.1016/S0022-1759(99)00138-6&rft_dat=%3Cproquest_cross%3E69415712%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17445303&rft_id=info:pmid/10648925&rft_els_id=S0022175999001386&rfr_iscdi=true |